Summary
The global oncology biosimilars market offers opportunities due to the rising cancer prevalence and high costs of biologics. Biosimilars can lower treatment costs, improve access, and increase competition. Growth is expected across drug types, cancer types, d
Source: GlobeNewswire
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
